The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Peptic Ulcer Testing-Global Market Insights and Sales Trends 2024
Synopsis
Stomach ulcers, which are also known as gastric ulcers, are painful sores in the stomach lining. Stomach ulcers are a type of peptic ulcer disease. Peptic ulcers are any ulcers that affect both the stomach and small intestines.
The global Peptic Ulcer Testing market size is expected to reach US$ 724.1 million by 2029, growing at a CAGR of 8.0% from 2023 to 2029. The market is mainly driven by the significant applications of Peptic Ulcer Testing in various end use industries. The expanding demands from the Hospitals, Laboratories and Others,, are propelling Peptic Ulcer Testing market. Blood Tests, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Elisa Tests segment is estimated at % CAGR for the next seven-year period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Peptic Ulcer Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Peptic Ulcer Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Peptic Ulcer Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Peptic Ulcer Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Peptic Ulcer Testing covered in this report include Bio-Rad Laboratories, Inc., Diasorin S.P.A., Ekf Diagnostics, Exalenz Bioscience Ltd., Halyard Health Inc., Kibion AB, Biomerieux S.A., Meridian Bioscience Inc. and Otsuka America, etc.
The global Peptic Ulcer Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bio-Rad Laboratories, Inc.
Diasorin S.P.A.
Ekf Diagnostics
Exalenz Bioscience Ltd.
Halyard Health Inc.
Kibion AB
Biomerieux S.A.
Meridian Bioscience Inc.
Otsuka America
Biomerica, Inc.
Biohit Oyjpharmaceutical, Inc.
Orion Diagnostica OY
Polymedco Cdp, LLC
Quidel Corporation
Global Peptic Ulcer Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Peptic Ulcer Testing market, Segment by Type:
Blood Tests
Elisa Tests
Urea Breath Test
Stool Tests
Others
Global Peptic Ulcer Testing market, by Application
Hospitals
Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Peptic Ulcer Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Stomach ulcers, which are also known as gastric ulcers, are painful sores in the stomach lining. Stomach ulcers are a type of peptic ulcer disease. Peptic ulcers are any ulcers that affect both the stomach and small intestines.
The global Peptic Ulcer Testing market size is expected to reach US$ 724.1 million by 2029, growing at a CAGR of 8.0% from 2023 to 2029. The market is mainly driven by the significant applications of Peptic Ulcer Testing in various end use industries. The expanding demands from the Hospitals, Laboratories and Others,, are propelling Peptic Ulcer Testing market. Blood Tests, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Elisa Tests segment is estimated at % CAGR for the next seven-year period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Peptic Ulcer Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Peptic Ulcer Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Peptic Ulcer Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Peptic Ulcer Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Peptic Ulcer Testing covered in this report include Bio-Rad Laboratories, Inc., Diasorin S.P.A., Ekf Diagnostics, Exalenz Bioscience Ltd., Halyard Health Inc., Kibion AB, Biomerieux S.A., Meridian Bioscience Inc. and Otsuka America, etc.
The global Peptic Ulcer Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bio-Rad Laboratories, Inc.
Diasorin S.P.A.
Ekf Diagnostics
Exalenz Bioscience Ltd.
Halyard Health Inc.
Kibion AB
Biomerieux S.A.
Meridian Bioscience Inc.
Otsuka America
Biomerica, Inc.
Biohit Oyjpharmaceutical, Inc.
Orion Diagnostica OY
Polymedco Cdp, LLC
Quidel Corporation
Global Peptic Ulcer Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Peptic Ulcer Testing market, Segment by Type:
Blood Tests
Elisa Tests
Urea Breath Test
Stool Tests
Others
Global Peptic Ulcer Testing market, by Application
Hospitals
Laboratories
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Peptic Ulcer Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Peptic Ulcer Testing
1.1 Peptic Ulcer Testing Market Overview
1.1.1 Peptic Ulcer Testing Product Scope
1.1.2 Peptic Ulcer Testing Market Status and Outlook
1.2 Global Peptic Ulcer Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Peptic Ulcer Testing Market Size by Region (2018-2029)
1.4 Global Peptic Ulcer Testing Historic Market Size by Region (2018-2023)
1.5 Global Peptic Ulcer Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Peptic Ulcer Testing Market Size (2018-2029)
1.6.1 North America Peptic Ulcer Testing Market Size (2018-2029)
1.6.2 Europe Peptic Ulcer Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Peptic Ulcer Testing Market Size (2018-2029)
1.6.4 Latin America Peptic Ulcer Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Peptic Ulcer Testing Market Size (2018-2029)
2 Peptic Ulcer Testing Market by Type
2.1 Introduction
2.1.1 Blood Tests
2.1.2 Elisa Tests
2.1.3 Urea Breath Test
2.1.4 Stool Tests
2.1.5 Others
2.2 Global Peptic Ulcer Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Peptic Ulcer Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Peptic Ulcer Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Peptic Ulcer Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Peptic Ulcer Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Peptic Ulcer Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Peptic Ulcer Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Peptic Ulcer Testing Revenue Breakdown by Type (2018-2029)
3 Peptic Ulcer Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Laboratories
3.1.3 Others
3.2 Global Peptic Ulcer Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Peptic Ulcer Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Peptic Ulcer Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Peptic Ulcer Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Peptic Ulcer Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Peptic Ulcer Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Peptic Ulcer Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Peptic Ulcer Testing Revenue Breakdown by Application (2018-2029)
4 Peptic Ulcer Testing Competition Analysis by Players
4.1 Global Peptic Ulcer Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peptic Ulcer Testing as of 2022)
4.3 Date of Key Players Enter into Peptic Ulcer Testing Market
4.4 Global Top Players Peptic Ulcer Testing Headquarters and Area Served
4.5 Key Players Peptic Ulcer Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Peptic Ulcer Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bio-Rad Laboratories, Inc.
5.1.1 Bio-Rad Laboratories, Inc. Profile
5.1.2 Bio-Rad Laboratories, Inc. Main Business
5.1.3 Bio-Rad Laboratories, Inc. Peptic Ulcer Testing Products, Services and Solutions
5.1.4 Bio-Rad Laboratories, Inc. Peptic Ulcer Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Bio-Rad Laboratories, Inc. Recent Developments
5.2 Diasorin S.P.A.
5.2.1 Diasorin S.P.A. Profile
5.2.2 Diasorin S.P.A. Main Business
5.2.3 Diasorin S.P.A. Peptic Ulcer Testing Products, Services and Solutions
5.2.4 Diasorin S.P.A. Peptic Ulcer Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Diasorin S.P.A. Recent Developments
5.3 Ekf Diagnostics
5.3.1 Ekf Diagnostics Profile
5.3.2 Ekf Diagnostics Main Business
5.3.3 Ekf Diagnostics Peptic Ulcer Testing Products, Services and Solutions
5.3.4 Ekf Diagnostics Peptic Ulcer Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Exalenz Bioscience Ltd. Recent Developments
5.4 Exalenz Bioscience Ltd.
5.4.1 Exalenz Bioscience Ltd. Profile
5.4.2 Exalenz Bioscience Ltd. Main Business
5.4.3 Exalenz Bioscience Ltd. Peptic Ulcer Testing Products, Services and Solutions
5.4.4 Exalenz Bioscience Ltd. Peptic Ulcer Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Exalenz Bioscience Ltd. Recent Developments
5.5 Halyard Health Inc.
5.5.1 Halyard Health Inc. Profile
5.5.2 Halyard Health Inc. Main Business
5.5.3 Halyard Health Inc. Peptic Ulcer Testing Products, Services and Solutions
5.5.4 Halyard Health Inc. Peptic Ulcer Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Halyard Health Inc. Recent Developments
5.6 Kibion AB
5.6.1 Kibion AB Profile
5.6.2 Kibion AB Main Business
5.6.3 Kibion AB Peptic Ulcer Testing Products, Services and Solutions
5.6.4 Kibion AB Peptic Ulcer Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Kibion AB Recent Developments
5.7 Biomerieux S.A.
5.7.1 Biomerieux S.A. Profile
5.7.2 Biomerieux S.A. Main Business
5.7.3 Biomerieux S.A. Peptic Ulcer Testing Products, Services and Solutions
5.7.4 Biomerieux S.A. Peptic Ulcer Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Biomerieux S.A. Recent Developments
5.8 Meridian Bioscience Inc.
5.8.1 Meridian Bioscience Inc. Profile
5.8.2 Meridian Bioscience Inc. Main Business
5.8.3 Meridian Bioscience Inc. Peptic Ulcer Testing Products, Services and Solutions
5.8.4 Meridian Bioscience Inc. Peptic Ulcer Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Meridian Bioscience Inc. Recent Developments
5.9 Otsuka America
5.9.1 Otsuka America Profile
5.9.2 Otsuka America Main Business
5.9.3 Otsuka America Peptic Ulcer Testing Products, Services and Solutions
5.9.4 Otsuka America Peptic Ulcer Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Otsuka America Recent Developments
5.10 Biomerica, Inc.
5.10.1 Biomerica, Inc. Profile
5.10.2 Biomerica, Inc. Main Business
5.10.3 Biomerica, Inc. Peptic Ulcer Testing Products, Services and Solutions
5.10.4 Biomerica, Inc. Peptic Ulcer Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Biomerica, Inc. Recent Developments
5.11 Biohit Oyjpharmaceutical, Inc.
5.11.1 Biohit Oyjpharmaceutical, Inc. Profile
5.11.2 Biohit Oyjpharmaceutical, Inc. Main Business
5.11.3 Biohit Oyjpharmaceutical, Inc. Peptic Ulcer Testing Products, Services and Solutions
5.11.4 Biohit Oyjpharmaceutical, Inc. Peptic Ulcer Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Biohit Oyjpharmaceutical, Inc. Recent Developments
5.12 Orion Diagnostica OY
5.12.1 Orion Diagnostica OY Profile
5.12.2 Orion Diagnostica OY Main Business
5.12.3 Orion Diagnostica OY Peptic Ulcer Testing Products, Services and Solutions
5.12.4 Orion Diagnostica OY Peptic Ulcer Testing Revenue (US$ Million) & (2018-2023)
5.12.5 Orion Diagnostica OY Recent Developments
5.13 Polymedco Cdp, LLC
5.13.1 Polymedco Cdp, LLC Profile
5.13.2 Polymedco Cdp, LLC Main Business
5.13.3 Polymedco Cdp, LLC Peptic Ulcer Testing Products, Services and Solutions
5.13.4 Polymedco Cdp, LLC Peptic Ulcer Testing Revenue (US$ Million) & (2018-2023)
5.13.5 Polymedco Cdp, LLC Recent Developments
5.14 Quidel Corporation
5.14.1 Quidel Corporation Profile
5.14.2 Quidel Corporation Main Business
5.14.3 Quidel Corporation Peptic Ulcer Testing Products, Services and Solutions
5.14.4 Quidel Corporation Peptic Ulcer Testing Revenue (US$ Million) & (2018-2023)
5.14.5 Quidel Corporation Recent Developments
6 North America
6.1 North America Peptic Ulcer Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Peptic Ulcer Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Peptic Ulcer Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Peptic Ulcer Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Peptic Ulcer Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Peptic Ulcer Testing Market Dynamics
11.1 Peptic Ulcer Testing Industry Trends
11.2 Peptic Ulcer Testing Market Drivers
11.3 Peptic Ulcer Testing Market Challenges
11.4 Peptic Ulcer Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
